Found 489 hits.
| 58. | Weller, K., Soost, S., Worm, M., Maurer, M., and Zuberbier, T.: Atopic dermatitis and allergic rhinitis – do co-effects in therapy exist? J. Dtsch. Dermatol. Ges. 2012: 10; 221-239. IF: 1.40 |
| 26. | Maurer, M. and Zuberbier, T.: Hypersensitivity vasculitis. In: Akdis, C. A. and Agache, I., editors: Global atlas of allergy. EAACI, 2014 |
| 17. | Metz, M. and Maurer, M.: Mast cells – key effector cells in immune responses. Trends Immunol. 2007: 28; 234-241. IF: 9.48 |
| 67. | Sánchez-Borges, M., Asero, R., Ansotegui, I. J., Baiardini, I., Bernstein, J. A., Canonica, G. W., Gower, R., Kahn, D. A., Kaplan, A. P., Katelaris, C., Maurer, M., Sim Park, H., Potter, P., Saini, S., Tassinari, P., Tedeschi, A., Min Ye, Y., Zuberbier, T., and the WAO Scientific and Clinical Issues Council: Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ. J. 2012: 5; 125-147. IF: N/A |
r.067
| 159. | Saini, S., Shams, M., Bernstein, J. A., and Maurer, M.+: Urticaria and Angioedema across the ages. J. Allergy Clin. Immunol. Pract. 2020: 6; 1866-1874. IF: 8.86 |
r.159
| 206 | Hawro, T., Zalewska, A., Hawro, M., Kaszuba, A., Królikowska, M., and Maurer M.+: Impact of psoriasis severity on family income and quality of life. J. Eur. Acad. Dermatol. Venereol. 2015: 29; 438-443. IF: TBD 2.82 |
| 208 | Hawro, T., Bogucki, A., Krupińska-Kun, M., Maurer, M.+, and Woźniacka, A.: Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS ONE 2015: 10; e0119911. IF: 3.05 |
o.208
| 15. | Zuberbier, T. and Maurer, M.: Antihistamines in the treatment of urticaria. In: Thurmond, R. L., editor: Histamine in inflammation. Texas: Springer Science + Business Media, LLC, Landes Bioscience, 2010 |
| 109 | Eller, K., Wolf, D., Huber, J. M., Metz, M., Mayer, G., McKenzie A. N. J., Maurer, M. Rosenkranz, A. R.+, and Wolf, A. M.: IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune-suppression. J. Immunol. 2011: 186; 83-91. IF: 5.78 |
| 290 | Suender, C. A., Leist, M., Abrink, M., Valentin, P., Geldmacher, A., Steinhoff, M., Metz, M., and Maurer, M.+: Mast cells are critical for the limitation of thrombin-induced skin inflammation. Exp. Dermatol. 2018: 27; 50-57. IF: 2.87 |